View Older Stories View More Recent Stories
-
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
-
Lyft rattles Wall Street as margins suffer in race with Uber
-
Editas Medicine Announces First Quarter 2023 Results and Business Updates
-
Summit Midstream Partners, LP Reports First Quarter 2023 Financial and Operating Results
-
PBF Energy boosts buyback plan, beats Q1 on robust margins
-
eHealth, Inc. to Present at 2023 RBC Capital Markets Global Healthcare Conference on May 16th, to Host Investor & Analyst Day on May 18th
-
MindMed Reports First Quarter 2023 Financial Results and Business Highlights
-
Kellogg's pricing actions help bolster annual forecasts
-
Compass Minerals Appoints Jill Gardiner as Independent Director
-
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
-
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
-
Aptose to Participate in RBC Capital Markets 2023 Global Healthcare Conference
-
HF Sinclair's bid for Holly Energy overshadows profit beat, shares down
-
Kenvue (KVUE) Prices Upsized 172.18M Share IPO at $22/sh
-
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
-
Callon Petroleum (CPE) to Acquire Core Delaware Basin Assets and Exit Eagle Ford
-
Callon to Acquire Core Delaware Basin Assets and Exit Eagle Ford
-
Brookdale to Present at the 2023 RBC Capital Markets Global Healthcare Conference
-
Thorne HealthTech to Participate in the 2023 RBC Capital Markets Global Healthcare Conference on May 16
-
Zynex, Inc. (ZYXI) Announces Proposed 2M Share Secondary Offering
-
Zynex Announces Proposed Secondary Public Offering of Common Stock
-
Flywire to Attend Upcoming Investor Conferences
-
Phillips 66 joins rivals to beat profit estimates as refining margins soar
-
R1 RCM to Present at Upcoming Investor Conferences
-
Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
-
Spruce Biosciences to Participate in May Investor Conferences
-
Morphic Therapeutic (MORF) Announces Proposed Public Offering
-
Morphic Therapeutic Announces Proposed Public Offering
-
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
-
Emera Issues $500 Million Principal Amount of Senior Unsecured Notes Due May 2, 2030
-
S&P Global Completes Sale of Engineering Solutions Business
-
89bio to Participate in Upcoming Investor Conferences
-
Edgewise Therapeutics to Present at Upcoming Investor Conferences
-
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
-
89bio to Participate in Upcoming Investor Conferences
-
Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
-
Karuna Therapeutics to Present at Upcoming Investor Conferences
-
Hershey Foods (HSY) Prices $750M in Notes Offerings
-
California Resources Corporation Reports Record First Quarter Financial Results, Provides an Update on the Progress of Business Repositioning and Further Expands Its Carbon Management Business
-
Qantas picks first female CEO as Alan Joyce prepares to depart
-
The Hershey Company Announces Pricing Of $350,000,000 4.250% Notes Due 2028 And $400,000,000 4.500% Notes Due 2033
-
Healthpeak Properties Inc. (PEAK) Prices Add-On $350M Senior Unsecured Notes Offering
-
Healthpeak Prices Add-On Offering of $350 Million of 5.250% Senior Unsecured Notes due 2032
-
Gilead Sciences to Present at Upcoming Investor Conferences
-
Hershey Foods (HSY) Announces Notes Offering
-
THE HERSHEY COMPANY ANNOUNCES OFFERING OF NOTES
-
Midwest Holding (MDWT) To Be Acquired By Antarctica Capital For $27 Per Share
-
Midwest Holding Inc. To Be Acquired By Antarctica Capital For $27.00 Per Share
-
Teton Merger Corp. Announces Extension of Tender Offers and Consent Solicitations for Senior Notes of TEGNA Inc.
-
Verastem Oncology to Participate in Upcoming Investor Conferences

